Cargando…
Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2
This case report describes the clinical characteristics of a 50-year-old woman that developed SARS-CoV-2 pneumonia and was admitted at the COVID-19 dedicated unit where she developed neurological symptoms 10 days after admission. After neurological examination, including a panel of blood cerebrospin...
Autores principales: | Manganotti, Paolo, Pesavento, Valentina, Buoite Stella, Alex, Bonzi, Lucia, Campagnolo, Elena, Bellavita, Giulia, Fabris, Bruno, Luzzati, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288617/ https://www.ncbi.nlm.nih.gov/pubmed/32529516 http://dx.doi.org/10.1007/s13365-020-00858-9 |
Ejemplares similares
-
Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID‐19 neuropathy patients
por: Manganotti, Paolo, et al.
Publicado: (2021) -
Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients
por: Manganotti, Paolo, et al.
Publicado: (2021) -
Pediatric Miller Fisher Syndrome; Characteristic Presentation and Comparison with Adult Miller Fisher Syndrome
por: Jang, Yeonji, et al.
Publicado: (2020) -
Recurrent Miller Fisher Syndrome
por: Ooi, Say Ting, et al.
Publicado: (2022) -
SARS-CoV-2 associated Miller-Fisher syndrome or polyneuritis cranialis
por: Finsterer, Josef
Publicado: (2021)